Drug Search Results
More Filters [+]

Segesterone

Alternative Names: segesterone, ANNOVERA
Latest Update: 2024-09-11
Latest Update Note: News Article

Product Description

Segesterone acetate is available in the United States in a combination contraceptive vaginal ring (Annovera) that releases segesterone acetate and ethinyl estradiol.  (Sourced from: https://pubmed.ncbi.nlm.nih.gov/30371999/)

Mechanisms of Action: GnRH Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Vaginal

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: United States

Approved Indications: Pregnancy Outcomes

Known Adverse Events: Migraine Disorders | Abdominal Pain | Headache | Pain Unspecified | Pruritus | Candidiasis | Candidiasis, Vulvovaginal | Metrorrhagia | Vaginal Discharge | Diarrhea | Injuries/wounds Unspecified

Company: TherapeuticsMD
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Segesterone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Contraception

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ANNOV3454-3 PMR

P1

Completed

Contraception

2021-06-08

22%

ANNOV3454-2 PMR

P1

Completed

Contraception

2021-01-06

22%

Recent News Events